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Kinase inhibitor libraries
A recent paper from the Schultz group at Berkeley reports on the culmination of a long-
standing interest in kinase inhibitor libraries (N.S. Gray et al., Science, (1998), 281, 533-538).
Cyclin-dependent kinases (CDKs) play a pivotal role in the timing of cell division and
inappropriate function of these enzymes is characteristic of a number of cancers.
Consequently, inhibition of CDKs is a possible target for therapeutic intervention. Following
the known activity of the purine olomucine (1), several libraries of compounds were prepared
with the intention of selectively binding to the kinase ATP-binding site.
Solid-phase synthesis of 2,6,9 trisubstituted purines was achieved through nucleophilic
displacements of halogens in the 2 and 6 positions and Mitsunobu chemistry in the 9 position.
The most potent analogues, such as purvalanol B (2) were discovered to possess 3- and 4-
substituted anilines or benzylamines in the 6-position.
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The structural basis for the activity of these compounds was explored by determining the
crystal structure of the human CDK2-purvalanol B complex. It was found that the purine ring
is rotated relative to the position of the adenine ring of ATP, and that the C2 side-chain fits
into the ribose binding pocket. The N-6 aniline substituent points towards a region not
occupied in the CDK2-ATP complex and the 4-position of the aniline ring is subsequently
highly tolerant of various substituents making it a good site for structural modifications that
could tune physicochemical properties.
--------------------------------------------------------------------------------------------------------------
Sensor arrays
Several groups have investigated the development of artificial ‘electronic noses’, but recently a
paper described a new sensor methodology which allows analyte identification in solution (J.J.
Lavigne et al., J. Am. Chem. Soc., (1998), 120, 6429-6430). This first step towards an
‘electronic tongue’ uses derivatised resin beads and has the potential to be extended through
combinatorial chemistry.
Polyethylene glycol-polystyrene beads were derivatised with a number of different indicator
molecules and were placed into micromachined wells in Si/SiN wafers. These beads
represented the ‘taste buds’ and their response to analytes in solution including pH, calcium
and cerium ions was monitored by charge-coupled devices recording red, green and blue
transmitted light intensities. Using such an array, the simultaneous detection of several
analytes is possible and the development of further detectors through combinatorial methods
offers more sophisticated recognition protocols.
--------------------------------------------------------------------------------------------------------------
Oligosaccharide libraries
This column has frequently featured approaches to oligosaccharide libraries, mainly because
these products are important pharmacological agents, but also as the syntheses pose significant
synthetic problems. A recent paper from The Scripps Research Institute describes a useful
orthoganol protection strategy that extends the accessibility of oligosaccharide libraries made
in solution (C-H. Wong et al., J. Am. Chem. Soc., (1998), 120, 7137-7138).
The key advance described in this paper is an effective orthoganol protection-deprotection
strategy that allows the sequential removal of four different protecting groups from a core
building block (3). Each of the four hydroxyls is protected by a different group: chloroacetyl
(ClAc), p-methoxybenzyl (PMB), levulinyl (Lev), and tert-butyldiphenylsilyl (TBDPS)
selectively removed by sodium bicarbonate, trifluoroacetic acid, hydrazine and hydrogen
fluoride-pyridine respectively. After each deprotection the hydroxyl revealed can be coupled
with a choice of seven glycosyl donors to generate 56 disaccharides, 1176 trisaccharides, and
ultimately 38,416 pentasaccharides.
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This strategy has been used to prepare 45 protected oligosaccharides (4) in multimilligram
amounts. Work is in progress to increase the numbers of compounds synthesised and screen
for compounds that bind to lectins and antibodies.
